000			01527 a2200433 4500
005			20250515161457.0
264		0	_c20110401
008			201104s 0 0 fre d
022			_a1768-3114
024	7		_a10.1016/j.patbio.2008.12.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aServonnet, A
245	0	0	_a[HLA-B*5701 and abacavir hypersensitivity reaction]. _h[electronic resource]
260			_bPathologie-biologie _cDec 2010
300			_ae95-100 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAlleles
650	0	4	_aAnti-HIV Agents _xadverse effects
650	0	4	_aAntigen Presentation
650	0	4	_aDideoxynucleosides _xadverse effects
650	0	4	_aDrug Hypersensitivity _xepidemiology
650	0	4	_aGene Frequency
650	0	4	_aGenes, MHC Class I
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGenetic Testing
650	0	4	_aHIV Reverse Transcriptase _xantagonists & inhibitors
650	0	4	_aHLA-B Antigens _xgenetics
650	0	4	_aHumans
650	0	4	_aPeptide Fragments _ximmunology
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aReverse Transcriptase Inhibitors _xadverse effects
650	0	4	_aSequence Analysis, DNA
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
700	1		_aLeclercq, E
700	1		_aDelacour, H
700	1		_aCeppa, F
773	0		_tPathologie-biologie _gvol. 58 _gno. 6 _gp. e95-100
856	4	0	_uhttps://doi.org/10.1016/j.patbio.2008.12.001 _zAvailable from publisher's website
999			_c18685589 _d18685589